Table 3.
Radiation environment and its consequences at LEO and deep space radiation environment and its consequences at LEO and deep space and the biological impact
| Feature | Low Earth Orbit (LEO) | Deep space (Lunar/Mars) | |||
|---|---|---|---|---|---|
| Primary sources | Trapped protons (Van Allen Belts), Secondary neutrons | Galactic Cosmic Rays (GCR), Solar Particle Events (SPE) | |||
| Radiation quality | Predominantly Low-LET | High-LET (HZE ions: 56Fe, 28Si, etc.) | |||
| Geomagnetic shielding | Significant protection | None | |||
| Dose rate | ∼0.5–1.0 mSv/day | ∼1.5–2.5 mSv/day | |||
| Biological effect | Lower RBE; primarily oxidative stress | High RBE; complex DNA damage and persistent inflammation | |||
| Primary cardiovascular concern | Minor endothelial changes | Accelerated atherosclerosis; Myocardial fibrosis | |||
| Comparative radiation environments and biological impact | |||||
| Environment | Primary sources | Radiation field characteristics | Biological effectiveness (reference) | ||
| LEO (ISS) | GCR (modulated), trapped particles (SAA) | Mixed field; dominance of trapped protons; lower secondary neutron flux. | Baseline effectiveness for stochastic/tissue effects; primarily low-LET driven. | ||
| Deep space |
Unshielded GCR, SPE |
Mixed field; high-energy, high-Z (HZE) ions; significant secondary neutron flux. | Enhanced effectiveness for complex DNA damage and cardiovascular remodeling. | ||
Contrasts the distinct radiological profiles of Low Earth Orbit (LEO) and Deep Space (Lunar/Mars) missions, emphasizing the shift in biological risk as geomagnetic protection is lost. This data underscores the necessity for advanced shielding and countermeasure strategies as mission profiles move beyond the protection of the Van Allen Belts, where dose rates can more than double (reaching up to 2.5 mSv/day). Relative biological effectiveness (RBE) is not a fixed physical constant but is highly dependent on the specific biological endpoint, dose rate, and tissue type. In this context, enhanced effectiveness refers to the increased potency of high-Z and high-energy (HZE) ions inducing complex DNA damage, persistent oxidative stress, and late-term cardiovascular remodeling compared to low-LET reference radiation (e.g., 60Co\gamma- or terrestrial X-rays). The radiation environments of LEO and deep space both represent complex, mixed-field exposures. While the International Space Station (ISS) is significantly shielded by the Earth’s magnetosphere, GCR remains a primary exposure source, albeit with a spectrum shifted toward lower energies compared to interplanetary space. Furthermore, we acknowledge that relative biological effectiveness (RBE) is not a fixed physical constant but is highly dependent on the specific biological endpoint, such as cell death, chromosomal aberration, or the induction of inflammatory signaling in the vascular endothelium. In deep space, the increased prevalence of HZE ions and secondary neutrons leads to a higher ionization density (LET), which generally correlates with a higher RBE for late-term cardiovascular and stochastic outcomes compared to the proton-dominant environment of LEO.